NVIDIA's Kimberly Powell at BIO International Convention

Short summary

NVIDIA unveiled the BioNeMo Agent Toolkit at BIO2026, designed to power autonomous agents for life-science research and discovery workflows. Presented with Genentech CEO Ashley Magargee, the toolkit frames AI agents as essential infrastructure for accelerating biological research. This signals NVIDIA's strategic push into biotech-specific AI tooling and agent-based automation.

• •NVIDIA announced BioNeMo Agent Toolkit, a biotech-focused AI agent framework
• •Partnership with Genentech CEO suggests enterprise life-sciences adoption
• •Positions agents as core infrastructure for research acceleration

Generated with AI, which can make mistakes.